tiprankstipranks
Trending News
More News >
Marksans Pharma Limited (IN:MARKSANS)
:MARKSANS
India Market

Marksans Pharma Limited (MARKSANS) Income Statement

Compare
4 Followers

Marksans Pharma Limited Income Statement

Last quarter (Q1 2026), Marksans Pharma Limited's total revenue was ₹6.20B, an increase of 4.97% from the same quarter last year. In Q1, Marksans Pharma Limited's net income was ₹583.17M. See Marksans Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 26.23B₹ 21.77B₹ 18.52B₹ 14.80B₹ 13.68B
Gross Profit
₹ 14.79B₹ 11.03B₹ 9.31B₹ 7.32B₹ 7.50B
Operating Expenses
₹ 3.50B₹ 3.29B₹ 2.68B₹ 5.15B₹ 2.22B
Depreciation and Amortization
₹ 833.86M₹ 742.70M₹ 518.53M₹ 447.76M₹ 361.51M
EBITDA
₹ 5.29B₹ 5.09B₹ 3.99B₹ 3.01B₹ 3.46B
Operating Income
₹ 11.29B₹ 3.87B₹ 3.00B₹ 5.17B₹ 5.48B
Other Income/Expenses
₹ -6.25B₹ 360.31M₹ 378.41M₹ -2.69B₹ -2.46B
Pretax Income
₹ 5.04B₹ 4.24B₹ 3.38B₹ 2.48B₹ 3.02B
Net Income
₹ 3.81B₹ 3.14B₹ 2.66B₹ 1.85B₹ 2.39B
Per Share Metrics
Basic EPS
₹ 8.40₹ 6.92₹ 6.41₹ 4.51₹ 5.83
Diluted EPS
₹ 8.40₹ 6.92₹ 6.41₹ 4.51₹ 5.83
Weighted Average Shares Outstanding
453.06M 453.32M 415.40M 409.31M 409.31M
Weighted Average Shares Outstanding (Diluted)
453.06M 453.16M 415.40M 409.31M 409.31M
Currency in INR

Marksans Pharma Limited Earnings and Revenue History